SAN ANSELMO, CA -- (Marketwire) -- 11/07/12 -- Equity Solar, Inc., a company specifically established to commercialize a leading-edge solar photovoltaic (PV) technology, today announced that it has appointed David Maloney, Ph.D., to its Board of Directors effective October 29, 2012.

Dr. Maloney currently serves as Account Technology Director at Intermolecular. Prior to joining Intermolecular, Dr. Maloney spent fifteen years at DuPont/EKC Technology, where he held several roles, including US R&D and Applications Engineering Manager, Global Product Manager and Global Technology Director.

"We've had the privilege of getting to know Dave over the past few years, and have been very impressed with his technological know-how and business-oriented approach," said Equity Solar's Chairman Chester Aldridge. "Dave brings a wealth of industry experience as well as objectivity to our Board and we are looking forward to working with him as we bring our technology to market."

"I have had the opportunity to follow the progression of Equity Solar's ground-breaking technology very closely, and as I've gotten to know the team, I have been extremely impressed with the commercially astute approach the company is taking," said Dr. Maloney. "I welcome the opportunity to join Equity Solar's Board as an independent member."

About Equity Solar, Inc.

Equity Solar, Inc. was specifically formed to commercialize a leading-edge patented solar photovoltaic (PV) technology licensed from Special Materials Research and Technology (SPECMAT).

Equity Solar, Inc. was founded and incubated by the management team of US Equity Holdings. For more information, visit www.usequityholdings.com.